Skip to main content

3 Result(s)

within J Pischimarov Remove this filter

and

  1. No Access

    Article

    Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing

    Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15–~50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting path...

    A Zamò, J Pischimarov, M Schlesner, P Rosenstiel, R Bomben, H Horn, T Grieb… in Leukemia (2018)

  2. No Access

    Article

    The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum

    S Momose, S Weißbach, J Pischimarov, T Nedeva, E Bach, M Rudelius, E Geissinger… in Leukemia (2015)

  3. Article

    Open Access

    Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules

    Multiple myeloma (MM) is a largely incurable plasma cell malignancy with a poorly understood and heterogeneous clinical course. To identify potential, functionally relevant somatic mutations in MM, we performe...

    E Leich, S Weißbach, H-U Klein, T Grieb, J Pischimarov, T Stühmer… in Blood Cancer Journal (2013)

    Download PDF (1085 KB) View Article